Product Portfolio

Marketed Therapies

Below is a list of our company's marketed products. This information is intended only for U.S. residents.

For product information for other countries, please?visit your country's Biogen affiliate website.

?

BENEPALI?? (etanercept)?

BENEPALI? is the first etanercept biosimilar referencing Enbrel? approved in the European Union (EU).?

FAMPYRA? (prolonged-release fampridine tablets)

For further information on FAMPYRA in your country please?click here.

U.S. residents: For information, please visit?Acorda Therapeutics

?

FLIXABI?? (infliximab)

FLIXABI? is an infliximab biosimilar referencing Remicade? approved in the European Union (EU).?

IMRALDI? (adalimumab)

IMRALDI? is an adalimumab biosimilar referencing Humira? approved in the European Union (EU).

PLEGRIDY? ?(peginterferon beta-1a)

?

Partnered Therapies

We have a collaboration agreement with Genentech that entitles us to certain business and financial rights with respect to RITUXAN, GAZYVA and OCREVUS.?This information is intended only for U.S. residents.

?

?

?

?

?